For other countries, any question or an interest in distributing OncoDEEP in your country please contact us at email@example.com
OncoDNA announces the closing of a new equity round with EUR 7.7 million. This financing was subscribed by the historical shareholders and a new group of investors, led by Ackermans & van Haaren.
The funds will be used by OncoDNA to speed up its already promising international growth even more, develop its innovative SaaS (Software as a Service) platform, and further expand its reference network of oncologists around the world.
The new shares were subscribed for by both the historical shareholders(IPG/bio.be, Invest4OncoDNA, Sambrinvest, and Vinsovier) as well as a group of four new investors (Sofinim NV, an affiliate of Ackermans & van Haaren, SRIW, CPH, and Inventures). Post-capital increase, Ackermans & van Haaren will hold a 15% participation in the company.
The funds raised in this round will be used:
Click here to see the press release.
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.